Clinical Trials · NCT01518101
Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novartis Pharmaceuticals
- Enrollment
- 62
- Start date
- Jan 2012
- Locations
- 8 sites, Germany
- Primary endpoint
- Proportion of patients preferring each treatment regimen